Cerebrocostomandibular syndrome (CCMS)

Qu'est-ce que Cerebrocostomandibular syndrome (CCMS)?

This rare disease is a very rare genetic syndrome. There are currently 80 cases recorded, to date.

The syndrome mainly affects the development of the ribs and jaw of affected individuals.

However it also presents with a wide range of symptoms that affect many different parts and systems of the body.

This syndrome is also known as:
CCMS Rib Gap Defects With Micrognathia Rib-gap syndrome

Quelles sont les causes des changements génétiques Cerebrocostomandibular syndrome (CCMS)?

Les mutations du gène SNRPB ont été identifiées comme l'une des causes du syndrome. Cependant, des recherches continues peuvent découvrir d'autres gènes qui peuvent causer la maladie, car certaines personnes présentant les symptômes du syndrome ne présentent pas de mutations dans le gène SNRPB.

Jusqu'à présent, la majorité des cas de syndrome ont été le résultat de mutations de novo du gène.

Dans certains cas, un syndrome génétique peut être le résultat d'une mutation de novo et le premier cas d'une famille. Dans ce cas, il s'agit d'une nouvelle mutation génique qui se produit pendant le processus de reproduction.

Quels sont les principaux symptômes de Cerebrocostomandibular syndrome (CCMS)?

The main symptoms of the syndrome affect the ribs and jaw. Individuals often have ribs missing, or spaces between the ribs. They also have a narrow rib cage. Individuals are also born with a much smaller jaw than the average (micrognathia).

50% of individuals will suffer from scoliosis (sideways curvature of the spine).

The Pierre Robin sequence of symptoms is associated with this syndrome. This includes a cleft palate, a small jaw and a tongue that is positioned further back in the mouth than it should be.

Infants with the syndrome usually experience breathing and feeding difficulties as newborns. Surgery is often required in the first year of life to correct these issues.

An estimated 67% of individuals affected by the syndrome will suffer hearing loss.

50% of individuals will be affected by developmental delay. This may include intellectual disability as well.

Physical features associated with the syndrome include club feet, a small head, low weight and failure to thrive, and a short stature.

Individuals with the syndrome may also suffer from health conditions affecting the stomach, heart, kidneys and urinary tract.

Possible clinical traits/features:
Atresia of the external auditory canal, Malar flattening, Clinodactyly of the 5th finger, Congenital hip dislocation, Cleft soft palate, Bell-shaped thorax, Ectopic kidney, Conductive hearing impairment, Epicanthus, Elbow flexion contracture, Nasal speech, Kyphosis, Short stature, High palate, Hydranencephaly, Short humerus, Glossoptosis, Cognitive impairment, Postnatal growth retardation, Low-set ears, Long philtrum, 11 pairs of ribs, Neonatal respiratory distress, Intellectual disability, Intrauterine growth retardation, Multicystic kidney dysplasia, Micrognathia, Myelomeningocele, Microcephaly, Short hard palate, Ventricular septal defect, Scoliosis, Tracheomalacia, Thoracic hypoplasia, Calcaneal epiphyseal stippling, Autosomal dominant inheritance, Posteriorly rotated ears, Porencephalic cyst, Autosomal recessive inheritance, Webbed neck, Abnormality of the dentition, Cerebral calcification, Polyhydramnios, Anomalous rib insertion to vertebrae

Comment quelqu'un se fait-il tester pour Cerebrocostomandibular syndrome (CCMS)?

Les premiers tests de Cerebrocostomandibular syndrome (CCMS) peut commencer par un dépistage par analyse faciale, en passant par le FDNA Telehealth plateforme de télégénétique, qui permet d'identifier les marqueurs clés de la syndrome et souligner la nécessité de tests supplémentaires. Une consultation avec un conseiller génétique puis un généticien suivra. 

Sur la base de cette consultation clinique avec un généticien, les différentes options pour les tests génétiques seront partagées et le consentement sera recherché pour des tests supplémentaires.

Informations médicales sur Cerebrocostomandibular syndrome (CCMS)

The cardinal features are the presence at birth of a severe Pierre Robin sequence (a very small jaw, a U-shaped cleft palate and glossoptosis), posterior rib gaps, and mental retardation in about half of those who survive. Early death occurs in 40% of cases, due mainly to respiratory difficulties. Microcephaly occurs in only 20% of cases, and the small number of post mortems so far carried out have shown cerebral heterotopia and focal gliosis, but this is not constant. Survivors are short, have epicanthic folds, and the rib gaps might heal partially and give rise to pseudoarthroses. Ibba et al., (1997) reported a case diagnosed by ultrasound at prenatal diagnosis. There was increased nuchal transluceny at 11 weeks and micrognathia was noted at 12 weeks with failure to identify the ribs at 18 weeks. Plotz et al., (1996) provide a good review. Hannam et al., (2000) provide a good review of rib abnormalities in the neonate.
Affected sibs with apparently normal parents have been reported (Hennekam et al., (1985); Drossou-Agakidou et al., 1991). However, there is also a dominantly inherited form of cerebro-costo-mandibular syndrome which has speech delay, but a normal head circumference and a normal IQ (Leroy et al., 1981; Merlob et al., 1987; Flodmark and Wattsgard., 2001). In general the two types cannot be distinguished clinically. A further father and daughter pair was reported by Morin et al., (2001). The daughter was picked up by ultrasound examination at 16 weeks of gestation. In isolated cases the parents must be X-rayed.
Hennekam and Goldschmeding (1998) reported a female infant born at 34 weeks with a very severe form of the condition. There was total absence of ossification of the ribs, extreme micrognathia and also absence of the external auditory meati and inner ears. The authors suggest that the Myf5 and MyoD genes are candidates for this condition. Goosecoid is also a candidate.
Van den Ende et al., (1998) reported seven patients with the condition. One 12 year old boy (previously reported by Meinecke et al., 1987 and Schrander-Stumpel et al., 1996) attended a normal school but had bilateral hearing loss. A 36 year old female had normal psychodevelopment although her 14 month old daughter was affected and suffered severe perinatal asphyxia resulting in encephalopathy with cortical atrophy and convulsions. A 14 year old girl had normal psychomotor development. Previously unreported features including absence of auditory canal and subluxation of the radial head in one case and choanal atresia in another. Kirk and Ades (1998) reported a case with a hypoplastic left heart. James and Aftimos, (2003) reported an affected father and son. They reviewed literature and concluded that autosomal dominant and autosomal recessive cases cannot be distinguished on clinical features.
Mutations in the gene SNRPB have now been found to be causitive (Lynch et al., 2014, Bacrot et al., 2015)
Tooley et al. (2016) described 12 sporadic and 4 familial patients with cerebrocostomandibular syndrome. yndrome. SNRPB mutations were identified in 12 out of 14 patients for whom DNA was available (4 of them previously reported). The most typical features were severe micrognathia and reduced numbers of ribs with gaps. Other common features included cleft palate, respiratory distress and scoliosis. Horseshoe kidney, hypospadias, and septal heart defect were additional malformations. Microcephaly and significant developmental delay were present in a minority of patients. Key radiological findings were narrow thorax, multiple posterior rib gaps and abnormal costotransverse articulation. The authors also described a previously unknown feature - bilateral accessory ossicles arising from the hyoid bone.

* This information is courtesy of the L M D.
If you find a mistake or would like to contribute additional information, please email us at: [email protected]

Soyez plus rapide et plus précis Diagnóstico Genético!

Plus de 250,000 patients analysés avec succès!
N'attendez pas des années pour un diagnostic. Agissez maintenant et gagnez un temps précieux.

Commencer ici!

"Notre chemin vers un diagnostic de maladie rare a été un voyage de 5 ans que je ne peux décrire que comme une tentative de faire un road trip sans carte. Nous ne connaissions pas notre point de départ. Nous ne connaissions pas notre destination. Maintenant nous avons de l'espoir. "


Paula et Bobby
Parents de Lillie

Qu'est-ce que la FDNA Telehealth?

FDNA Telehealth est une entreprise de santé numérique de premier plan qui offre un accès plus rapide à une Analyse Génétique précise.

Dotée d'une technologie hospitalière recommandée par les plus grands généticiens, notre plateforme unique met les patients en contact avec des Experts En Génétique pour répondre à leurs questions les plus urgentes et clarifier toute préoccupation qu'ils pourraient avoir concernant leurs Symptômes.

Avantages de la FDNA Telehealth

Icône FDNA


Notre plateforme est actuellement utilisée par plus de 70% des généticiens et a été utilisée pour diagnostiquer plus de 250,000 patients dans le monde.

Icône FDNA


FDNA Telehealth fournit une analyse faciale et un dépistage en quelques minutes, suivi d'un accès rapide aux conseillers en génétique et aux généticiens.

Icône FDNA

Facilité d'utilisation

Notre processus transparent commence par un diagnostic initial en ligne par un conseiller en génétique et s'ensuit par des consultations avec des généticiens et des tests génétiques.

Icône FDNA

Précision et précision

Capacités et technologies avancées d'intelligence artificielle (IA) avec un taux de précision de 90% pour une meilleure précision analyse génétique.

Icône FDNA

La valeur pour
De l'argent

Accès plus rapide aux conseillers en génétique, aux généticiens, aux tests génétiques et au diagnostic. En moins de 24 heures si nécessaire. Économisez du temps et de l'argent.

Icône FDNA

Confidentialité et sécurité

Nous garantissons la meilleure protection de toutes les images et informations des patients. Vos données sont toujours sûres, sécurisées et cryptées.

La FDNA Telehealth peut vous rapprocher d'un diagnostic.
Planifiez une réunion de conseil ginitique en ligne dans les 72 heures!